Back to search

United Kingdom· GB-APID-42407311000001105

Slynd 4mg tablets

A drospirenone product containing drospirenone, registered in United Kingdom by Exeltis UK Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC G03AC10

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedSlynd 4mg tabletsATCG03AC10REGISTER NO.GB-APID-4240731100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Drospirenone is registered in 13 of 19 countries.

Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Drospirenone · ATC G03AC10

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Drospirenone
Manufacturer
Exeltis UK Ltd
Country
United Kingdom (GB)
ATC code
G03AC10
ATC class
Drospirenone
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    08437018658930

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

172 interactions on record for drospirenone.

Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Drospirenone · interactions on record

172 records

  • 27 severe
  • 143 moderate
  • 2 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • GriseofulvinD01AA08severe
  • GriseofulvinD01BA01severe
  • KetoconazoleH02CA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7d24ed1-8724-48cf-91af-b3975ffff3f4
GET /v1/drugs/a7d24ed1-8724-48cf-91af-b3975ffff3f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "42407311000001105",
  "desc": "Slynd 4mg tablets (Exeltis UK Ltd)",
  "form": "Oral tablet",
  "vpid": "42410211000001104",
  "source": "dmd",
  "vtm_id": "775706001",
  "strength": "4 mg",
  "substance": "Drospirenone",
  "ingredient": "Drospirenone",
  "supplier_code": "40599211000001108"
}

See everything about drospirenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.